Cargando…

Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?

Current clinical guidelines emphasize the unmet need for technological innovations to guide physician decision-making and to transit from conventional care to personalized cardiovascular medicine. Biomarker-guided cardiovascular therapy represents an interesting approach to inform tailored treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gonzalo-Calvo, David, Vea, Angela, Bär, Christian, Fiedler, Jan, Couch, Liam S, Brotons, Carlos, Llorente-Cortes, Vicenta, Thum, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528150/ https://www.ncbi.nlm.nih.gov/pubmed/29688487 http://dx.doi.org/10.1093/eurheartj/ehy234

Ejemplares similares

Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study
por: de Gonzalo-Calvo, David, et al.
Publicado: (2018)

Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes
por: de Gonzalo-Calvo, D., et al.
Publicado: (2016)

Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
por: Hobuß, Lisa, et al.
Publicado: (2019)

Facts and updates about cardiovascular non‐coding RNAs in heart failure
por: Thum, Thomas
Publicado: (2015)

Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems
por: Spinetti, Gaia, et al.
Publicado: (2023)

Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
por: Garg, Ankita, et al.
Publicado: (2021)

Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure
por: Couch, Liam S, et al.
Publicado: (2021)

Association of Circulating microRNAs with Coronary Artery Disease and Usefulness for Reclassification of Healthy Individuals: The REGICOR Study
por: Dégano, Irene R., et al.
Publicado: (2020)

Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration
por: Hunkler, Hannah J, et al.
Publicado: (2021)

Circulating microRNAs in Fabry Disease
por: Xiao, Ke, et al.
Publicado: (2019)

Molecular Mechanisms of Takotsubo Syndrome
por: Couch, Liam S., et al.
Publicado: (2022)

Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction
por: Jung, Mira, et al.
Publicado: (2018)

Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration
por: Abbas, Naisam, et al.
Publicado: (2020)

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
por: de Gonzalo-Calvo, David, et al.
Publicado: (2020)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis
por: Grosse, Gerrit M., et al.
Publicado: (2021)

Plasma microRNA Profiling Reveals Novel Biomarkers of Epicardial Adipose Tissue: A Multidetector Computed Tomography Study
por: de Gonzalo-Calvo, David, et al.
Publicado: (2019)

Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?
por: Bär, Christian, et al.
Publicado: (2021)

LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells
por: Actis Dato, Virginia, et al.
Publicado: (2020)

MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2017)

Non-coding RNAs in cardiovascular health and disease
por: Boon, Reinier A.
Publicado: (2018)

Extracellular Non-Coding RNAs in Cardiovascular Diseases
por: Jiapaer, Zeyidan, et al.
Publicado: (2023)

Immunization with the Gly(1127)-Cys(1140) amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies
por: Bornachea, Olga, et al.
Publicado: (2020)

Relationship among LRP1 expression, Pyk2 phosphorylation and MMP‐9 activation in left ventricular remodelling after myocardial infarction
por: Revuelta‐López, Elena, et al.
Publicado: (2017)

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
por: Sabre, Liis, et al.
Publicado: (2020)

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis
por: Di Mauro, Stefania, et al.
Publicado: (2020)

Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease
por: Kataoka, Masaharu, et al.
Publicado: (2014)

The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease
por: Zhao, Yanfang, et al.
Publicado: (2019)

Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome
por: Dandare, Abdullahi, et al.
Publicado: (2022)

Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2018)

Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy
por: Roura, Santiago, et al.
Publicado: (2017)

Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology
por: Iaconetti, Claudio, et al.
Publicado: (2013)

Deciphering Non-coding RNAs in Cardiovascular Health and Disease
por: Das, Anindita, et al.
Publicado: (2018)

Online Databases and Non-coding RNAs in Cardiovascular Diseases
por: Chen, Rui, et al.
Publicado: (2019)

The Role of Long Non-Coding RNAs in Cardiovascular Diseases
por: Le, Linh T. T., et al.
Publicado: (2023)

Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases
por: Zhao, Guoan
Publicado: (2018)

Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases
por: Singh, Desh Deepak, et al.
Publicado: (2023)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hlr4rdfd4m5gqdii08092orbp8